<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-049961</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Application of a protocol for pregnant women with classic phenylketonuria: three successful pregnancies</dc:title>
<dc:description xml:lang="en">Maternal phenylketonuria syndrome(MPS)occurs in children whose mothers have severe or moderate hyperphenylalaninemia and present high plasma phenylalanine levels during the months prior to and/or throughout pregnancy. MPS presents with malformations similar to those associated with fetal alcohol syndrome, the most common of which are microcephaly, congenital heart defects and mental and developmental retardation. Planning and strict control of phenylalanine levels during pregnancy are essential for the prevention of the development of MPS. We present a follow-up protocol and our experience with three successful pregnancies in women with phenylketonuria</dc:description>
<dc:creator>Gómez López, L</dc:creator>
<dc:creator>Lambruschini Ferri, N</dc:creator>
<dc:creator>Campistal Plana, J</dc:creator>
<dc:creator>Gutiérrez Sánchez, A</dc:creator>
<dc:creator>Pérez-Dueñas, B</dc:creator>
<dc:creator>Vilaseca Busca, M. A</dc:creator>
<dc:creator>Fusté, E</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de fenilcetonuria materna (SFM) aparece en hijos de madres afectadas por hiperfenilalaninemia grave o moderada con concentraciones plasmáticas elevadas de fenilalanina(Phe) durante los meses previos y/o la gestación. Cursa con malformaciones similares al síndrome alcoholico fetal y es especialmente frecuente la aparición de microcefalia y retardomental y del desarrollo. La planificación y los controles estrictos de Phe durante el embarazo son fundamentales para evitar la aparición de SFM. Presentamos un protocolo de seguimiento y nuestra experiencia en tres embarazos que han finalizado con éxito</dc:description>
<dc:source>Acta Pediatr Esp;64(5): 225-231, mayo 2006. tab</dc:source>
<dc:identifier>ibc-049961</dc:identifier>
<dc:title xml:lang="es">Aplicación del protocolo de actuación para embarazadas con fenilcetonuria clásica: tres gestaciones con éxito</dc:title>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d9020^s22027</dc:subject>
<dc:subject>^d28625</dc:subject>
<dc:subject>^d11086^s22012</dc:subject>
<dc:subject>^d27977</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29896^s22067</dc:subject>
<dc:subject>^d6483^s22027</dc:subject>
<dc:subject>^d11074^s22002</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>200605</dc:date>
</metadata>
</record>
</ibecs-document>
